Pregnancy and Perinatal Outcomes of Women with COVID-19 Pneumonia: A Preliminary Analysis

Liu, Dehan; Li, Lin; Wu, Xin; Zheng, Dandan; Wang, Jiazheng; Liu, Bo; Yang, Lian; Zheng, Chuansheng

doi:10.2139/ssrn.3548758

Cited by 35 publications

(34 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the Chen study and Zhang study, none of the nine patients established severe pneumonia or died [8,12]. Fever and fatigue were the chief symptoms, and less common symptoms were sore throat and shortness of breath [10,13]. 92% of pregnant women had a clear epidemiologic history, either with other family members affected or with linkage to infected person and 23% improved after hospitalization [10].…”

Section: Symptoms Of the Covid-19 In Pregnancymentioning

confidence: 99%

“…Favre recommended that systematic screening of any suspected COVID-19 infection during pregnancy [16]. e. The mother should be admitted to an isolation room for care, and samples should be collected to early diagnosis and treatment, if symptoms such as fever, coughing, and poor mental status are present [13,15]. f. Chest CT scanning has high sensitivity for the diagnosis of COVID-19 [13].…”

Section: Pregnancy Managementmentioning

confidence: 99%

“…e. The mother should be admitted to an isolation room for care, and samples should be collected to early diagnosis and treatment, if symptoms such as fever, coughing, and poor mental status are present [13,15]. f. Chest CT scanning has high sensitivity for the diagnosis of COVID-19 [13]. In a pregnant woman with suspected COVID-19 infection, a chest CT scan may be considered as a tool for the detection of COVID-19 in epidemic zones [13].…”

Section: Pregnancy Managementmentioning

confidence: 99%

“…f. Chest CT scanning has high sensitivity for the diagnosis of COVID-19 [13]. In a pregnant woman with suspected COVID-19 infection, a chest CT scan may be considered as a tool for the detection of COVID-19 in epidemic zones [13]. g. Pregnant women with COVID-19 infection should be observed with 2-4-weekly ultrasound assessment of fetal growth and amniotic fluid volume, with umbilical artery Doppler if necessary [18].…”

Section: Pregnancy Managementmentioning

confidence: 99%

“…Antiproteases Lopinavir/Ritonavir has been the preferred drug regimen as it is known to be relatively safe in pregnancy [19]. In the Liu study, pregnant women were not only treated with antiviral drugs, but also achieved good recovery [13].…”

Section: Pregnancy Managementmentioning

confidence: 99%

See 4 more Smart Citations

Improving the quality of care in pregnancy and childbirth with coronavirus (COVID-19): a systematic review

Abdollahpour

Khadivzadeh

2020

The Journal of Maternal-Fetal & Neonatal Medicine

View full text Add to dashboard Cite

In the context of serious coronavirus epidemic, it is critical that pregnant women not be ignored potentially life-saving interventions. So, this study was designed to improve the quality of care by health providers through what they need to know about coronavirus during pregnancy and childbirth. We conducted a systematic review of electronic databases was performed for published in English, before 25 March 2020. Finally, 29 papers which had covered the topic more appropriately were included in the study. The results of the systematic review of the existing literature are presented in the following nine sections: Symptoms of the COVID-19 in pregnancy, Pregnancy management, Delivery Management, Mode of delivery, Recommendations for health care provider in delivery, Neonatal outcomes, Neonatal care, Vertical Transmission, Breastfeeding. In conclusion, improving quality of care in maternal health, as well as educating, training, and supporting healthcare providers in infection management to be prioritized. Sharing data can help to countries that to prevent maternal and neonatal morbidity associated with the COVID-19.

show abstract

Section: Symptoms Of the Covid-19 In Pregnancymentioning

confidence: 99%

Section: Pregnancy Managementmentioning

confidence: 99%

Section: Pregnancy Managementmentioning

confidence: 99%

Section: Pregnancy Managementmentioning

confidence: 99%

Section: Pregnancy Managementmentioning

confidence: 99%

See 3 more Smart Citations

Improving the quality of care in pregnancy and childbirth with coronavirus (COVID-19): a systematic review

Abdollahpour

Khadivzadeh

2020

The Journal of Maternal-Fetal & Neonatal Medicine

View full text Add to dashboard Cite

show abstract

Segmentation of CT-Scan Images Using UNet Network for Patients Diagnosed with COVID-19

Gois

Marques

2023

Computerized Systems for Diagnosis and Treatment of COVID-19

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases

2020

View full text Add to dashboard Cite

The novel coronavirus outbreak induces many concerns about the management of pregnancy, as well as rheumatic and musculoskeletal diseases. The very rapid spread of the infection throughout all inhabited continents leads to a fast-growing number of infected with SARS-CoV-2 and requires answers and special recommendations to the most vulnerable group of people: pregnant woman and patients on immunomodulatory or immunosuppressive treatment. A systematic literature search was performed in Embase, MEDLINE, and Scopus database for studies describing COVID-19 infection in pregnant women diagnosed with rheumatic and musculoskeletal diseases. From the 1,115 initially identified articles, we selected 29 publications in the English language, from which 18 were eligible according to the inclusion criteria. Limited number of cases and further researches are required to evaluate the risk of transmission of SARS-CoV-2 from mother to her infant as well as clinical features of infection in pregnant women. The conclusions of different authors, despite the small number of cases, suggest that there is no vertical transmission in women diagnosed with COVID-19 pneumonia. Although the World Health Organization recently reported that pregnant patients do not have a higher risk of infection than the rest of the population, Royal College of Obstetricians & Gynecologists and The Royal College of Midwives for COVID-19 infection in pregnancy published Guidelines for pregnant women with suspected SARS-CoV-2 infection. Considerations about patients with rheumatic diseases on the immunosuppressive treatment required European League Against Rheumatism, American College of Rheumatology, British Society for Rheumatology, and Australian Rheumatology Association to publish recommendations for patients with rheumatic diseases and COVID-19. These algorithms are very important to the medical society, but many concerns, absence of experience, and many questions are still unanswered and need time to be resolved and proceed successfully in this global pandemic situation.

show abstract

Pregnancy and Perinatal Outcomes of Women with COVID-19 Pneumonia: A Preliminary Analysis

Cited by 35 publications

References 0 publications

Improving the quality of care in pregnancy and childbirth with coronavirus (COVID-19): a systematic review

Improving the quality of care in pregnancy and childbirth with coronavirus (COVID-19): a systematic review

Segmentation of CT-Scan Images Using UNet Network for Patients Diagnosed with COVID-19

Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases

Contact Info

Product

Resources

About